Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4
Clinical trial NCT04559204 · COMPLETED
Trial details
- NCT number
- NCT04559204
- Sponsor
- China National Biotec Group Company Limited
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-11
- Primary completion
- 2020-11-26
- Enrollment
- 1224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.